Skip to content

Buying Time: Improving Sleep to Promote Cognitive Function in Older Adults

Buying Time: Improving Sleep to Promote Cognitive Function in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02926157
Enrollment
96
Registered
2016-10-06
Start date
2016-10-31
Completion date
2018-12-31
Last updated
2019-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Sleep

Brief summary

The purpose of this study is to investigate whether a comprehensive group education combined with a lifestyle activation program that includes (a) sleep hygiene course, (b) physical activity promotion, and (c) bright light therapy, can improve both sleep quality and cognitive function among 96 community-dwelling older adults.

Detailed description

96 community-dwelling older adults with sleep complaints will be randomized into either a 6-month life style and sleep activation intervention program or a waitlist control group (participants in this group will be offered an abbreviated version of the program upon completion of the 6 month study). There are 3 measurement sessions to measure cognition, sleep, and physical activity at the onset of the study, the midway (3 month) point, and completion (at 6 months).

Interventions

BEHAVIORALLife Style and Sleep Intervention

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Sleep complaints * Community-dwelling (not in a long term care facility) * Read, write, and speak English * Able to walk independently * In sufficient health to participate in regular physical activity

Exclusion criteria

* Diagnosis of obstructive sleep apnea * Receiving continuous positive air pressure (CPAP) treatment * Diagnosed with dementia of any type * At high risk for cardiac complications during physical activity or unable to self-regulate activity or understand recommended activity level * Have a clinically important peripheral neuropathy or sever musculoskeletal or joint disease that impairs mobility

Design outcomes

Primary

MeasureTime frame
Change from baseline in sleep quality as measured by Motion Watch 8 at 3 and 6 monthsBaseline, 3 months, and 6 months

Secondary

MeasureTime frame
Change from baseline in cognitive function as measured by the Alzheimer's Disease Assessment Scale Cognitive Subscale Plus (ADAS-Plus) at 3 and 6 monthsBaseline, 3 months, and 6 months
Change from baseline in self-reported sleep quality as measured by the Pittsburgh Sleep Quality Index at 3 and 6 monthsBaseline, 3 months, and 6 months
Change from baseline in physical activity levels as measured by Motion Watch 8 at 3 and 6 monthsBaseline, 3 months, and 6 months
Change from baseline in self-reported physical activity levels as measured by CHAMPS physical activity questionnaire each monthMonthly, from baseline through 6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026